SEARCH

SEARCH BY CITATION

References

  • Allford, S.L., Harrison, P., Lawrie, A.S., Liesner, R., Mackie, I.J. & Machin, S.J. (2000) Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. British Journal of Haematology, 111, 12151222.DOI: 10.1046/j.1365-2141.2000.02503.x
  • Barbot, J., Costa, E., Guerra, M., Barreirinho, M.S., Isvarlal, P., Robles, R., Gerritsen, H.E., Lämmle, B. & Furlan, M. (2001) Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. British Journal of Haematology, 113, 649651.DOI: 10.1046/j.1365-2141.2001.02808.x
  • Fujikawa, K., Suzuki, H., McMullen, B. & Chung, D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood, 98, 16621666.
  • Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P. & Lämmle, B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 98, 30973103.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B. (1998a) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. New England Journal of Medicine, 339, 15781584.DOI: 10.1056/NEJM199811263392202
  • Furlan, M., Robles, R., Solenthaler, M. & Lämmle, B. (1998b) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood, 91, 28392846.
  • Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lämmle, B. & Furlan, M. (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 13861389.
  • Joseph, G., Smith, K.J., Hadley, T.J., Djulbegovic, B., Troup, G.M., Oldfather, J. & Barker, R.L. (1994) HLA-DR53 protects againstthrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome. American Journal of Hematolology, 47, 189193.
  • Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, S.P., Sabio, H., Bouhassira, E.E., Upshaw, J.D., Ginsburg, D. & Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488494.
  • Mant, M.J., Turner, A.R., Ritchie, D.B.C. & Larrat, L.M. (1999) Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange dependency. American Journal of Hematolology, 62, 5657.
  • Rock, G.A. (2000) Management of thrombotic thrombocytopenic purpura. British Journal of Haematology, 109, 496507.
  • Tsai, H.M. & Lian, E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 15851594.